127 related articles for article (PubMed ID: 25716664)
1. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.
Somajo S; Ahnström J; Fernandez-Recio J; Gierula M; Villoutreix BO; Dahlbäck B
Thromb Haemost; 2015 May; 113(5):976-87. PubMed ID: 25716664
[TBL] [Abstract][Full Text] [Related]
2. Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.
Teraz-Orosz A; Gierula M; Petri A; Jones D; Keniyopoullos R; Folgado PB; Santamaria S; Crawley JTB; Lane DA; Ahnström J
Blood Adv; 2022 Jan; 6(2):704-715. PubMed ID: 34731882
[TBL] [Abstract][Full Text] [Related]
3. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.
Reglińska-Matveyev N; Andersson HM; Rezende SM; Dahlbäck B; Crawley JT; Lane DA; Ahnström J
Blood; 2014 Jun; 123(25):3979-87. PubMed ID: 24740810
[TBL] [Abstract][Full Text] [Related]
4. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights.
Villoutreix BO; Dahlbäck B; Borgel D; Gandrille S; Muller YA
Proteins; 2001 May; 43(2):203-16. PubMed ID: 11276089
[TBL] [Abstract][Full Text] [Related]
6. Binding site for C4b-binding protein in vitamin K-dependent protein S fully contained in carboxy-terminal laminin-G-type repeats. A study using recombinant factor IX-protein S chimeras and surface plasmon resonance.
He X; Shen L; Malmborg AC; Smith KJ; Dahlback B; Linse S
Biochemistry; 1997 Mar; 36(12):3745-54. PubMed ID: 9132028
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain.
Van Wijnen M; Stam JG; Chang GT; Meijers JC; Reitsma PH; Bertina RM; Bouma BN
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):389-96. PubMed ID: 9461535
[TBL] [Abstract][Full Text] [Related]
8. Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S.
Ahnström J; Andersson HM; Hockey V; Meng Y; McKinnon TA; Hamuro T; Crawley JT; Lane DA
Blood; 2012 Dec; 120(25):5059-62. PubMed ID: 23074276
[TBL] [Abstract][Full Text] [Related]
9. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.
Peraramelli S; Suylen DP; Rosing J; Hackeng TM
Thromb Haemost; 2012 Aug; 108(2):266-76. PubMed ID: 22627666
[TBL] [Abstract][Full Text] [Related]
10. Studies of the interaction between human protein S and human C4b-binding protein using deletion variants of recombinant human protein S.
Chang GT; Maas BH; Ploos van Amstel HK; Reitsma PH; Bertina RM; Bouma BN
Thromb Haemost; 1994 Apr; 71(4):461-7. PubMed ID: 8052964
[TBL] [Abstract][Full Text] [Related]
11. Structural analyses of sex hormone-binding globulin reveal novel ligands and function.
Avvakumov GV; Cherkasov A; Muller YA; Hammond GL
Mol Cell Endocrinol; 2010 Mar; 316(1):13-23. PubMed ID: 19748550
[TBL] [Abstract][Full Text] [Related]
12. Role of exosite binding modulators in the inhibition of Fxa by TFPI.
Peraramelli S; Thomassen S; Heinzmann A; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M; Rosing J
Thromb Haemost; 2016 Mar; 115(3):580-90. PubMed ID: 26607136
[TBL] [Abstract][Full Text] [Related]
13. TFPI-dependent activities of protein S.
Peraramelli S; Rosing J; Hackeng TM
Thromb Res; 2012 May; 129 Suppl 2():S23-6. PubMed ID: 22425215
[TBL] [Abstract][Full Text] [Related]
14. SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations.
Villoutreix BO; García de Frutos P; Lövenklev M; Linse S; Fernlund P; Dahlbäck B
Proteins; 1997 Dec; 29(4):478-91. PubMed ID: 9408945
[TBL] [Abstract][Full Text] [Related]
15. Structure and biology of tissue factor pathway inhibitor.
Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
[TBL] [Abstract][Full Text] [Related]
16. Protein S is a cofactor for tissue factor pathway inhibitor.
Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
[TBL] [Abstract][Full Text] [Related]
17. Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein.
Waters EK; Genga RM; Thomson HA; Kurz JC; Schaub RG; Scheiflinger F; McGinness KE
J Thromb Haemost; 2013 Jun; 11(6):1137-45. PubMed ID: 23528042
[TBL] [Abstract][Full Text] [Related]
18. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
Lockett JM; Mast AE
Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
[TBL] [Abstract][Full Text] [Related]
19. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
[TBL] [Abstract][Full Text] [Related]
20. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function.
Nyberg P; Dahlbäck B; García de Frutos P
FEBS Lett; 1998 Aug; 433(1-2):28-32. PubMed ID: 9738926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
